Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Millions of Americans seeking weight loss turn to GLP-1 receptor agonists, the class of medications that includes Ozempic and Wegovy. These medications work by slowing stomach emptying and signaling fullness to the brain, helping users lose an average of 15–22% of body weight in clinical trials. PlexusDx offers compounded semaglutide and tirzepatide—two science-backed alternatives that deliver comparable results at predictable, affordable pricing.
How Semaglutide Works as an Ozempic Alternative
Semaglutide is the active ingredient in both Ozempic (for diabetes) and Wegovy (FDA-approved for weight loss). This medication mimics glucagon-like peptide-1 (GLP-1), a natural hormone that regulates blood sugar and appetite. By activating GLP-1 receptors in the brain, semaglutide reduces hunger signals and increases feelings of satisfaction after smaller meals. Clinical data shows users typically lose 10–15 pounds in the first month, with continued weight reduction over six to twelve months.
PlexusDx delivers compounded semaglutide injections prepared in licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and purity. Your dose may need to go up as your body adjusts, but your price won't—PlexusDx charges a flat $149/month starting rate regardless of dose level. This transparency makes it easier to budget for long-term weight management without surprise cost increases.
Tirzepatide: A Dual-Action Alternative with Stronger Results
Tirzepatide represents a next-generation advancement in GLP-1 therapy. Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism produces more robust appetite suppression and metabolic improvements. A 2023 clinical trial showed participants using tirzepatide lost an average of 20–22% of body weight—approximately 2–3 pounds more per month than comparable semaglutide studies.
PlexusDx offers compounded tirzepatide injections starting at $249/month, with access to all 50 states and no insurance requirement. The GLP-Squared Injection option combines semaglutide and tirzepatide into a single compound, starting at $249/month for patients seeking a hybrid approach. Like all PlexusDx medications, tirzepatide comes from licensed 503A compounding pharmacies and is HSA/FSA eligible.
Oral vs. Injectable GLP-1 Options at PlexusDx
Some patients prefer oral medications over weekly injections. PlexusDx offers oral semaglutide at $249/month and oral tirzepatide at $279/month, both compounded to pharmaceutical standards. Oral GLP-1 medications work through the same receptor pathways as injections, though absorption differs—oral formulations are typically taken on an empty stomach with specific timing requirements. Clinical trials show oral semaglutide produces similar weight loss outcomes to injectable forms when taken consistently.
The choice between injection and oral depends on personal preference, adherence patterns, and individual response. Some patients find injections easier to remember (once weekly), while others prefer daily oral dosing. PlexusDx also offers the Microdose GLP-1 Protocol at $129/month, a lower-dose injectable option suited for patients new to GLP-1 therapy or those with sensitivity to higher doses.
Personalized Treatment Through Genetic Testing
Not every patient responds identically to GLP-1 therapy. PlexusDx Precision Peptide Genetic Test identifies your genetic predispositions across 14 metabolic pathways and 49 peptides, revealing how your body may respond to semaglutide, tirzepatide, and other peptide-based medications. Key variants tested include GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—all linked to appetite regulation and weight loss potential. This $99 add-on test (available after your first month of treatment) informs your clinician about optimal medication selection and expected outcomes.
By matching your genetic profile to the right compound and dose trajectory, PlexusDx optimizes your chances of achieving meaningful, sustainable weight loss. Patients with favorable GLP1R variants often see faster response times, while those with specific FTO or MC4R patterns may benefit from tirzepatide's dual-receptor approach. This precision-health model moves beyond one-size-fits-all prescribing.
Cost, Access, and Insurance Coverage
PlexusDx operates independently of insurance systems—no membership fees, prior authorizations, or waiting periods. All medications are HSA/FSA eligible, meaning you can use pre-tax healthcare dollars to pay for treatment. Monthly pricing remains flat regardless of dose escalation: semaglutide injection starts at $149/month, tirzepatide injection at $249/month, and the Microdose Protocol at $129/month. This predictable cost structure eliminates the financial anxiety many patients experience with brand-name alternatives.
Medications ship to all 50 states and arrive refrigerated with clear, easy-to-follow injection or administration instructions. Each order includes access to PlexusDx's clinician team, who monitor your progress and adjust your regimen based on weekly check-ins and monthly assessments. Unlike urgent-care or telehealth-only models, PlexusDx provides ongoing medical supervision to ensure safety and efficacy throughout your treatment journey.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide the same as brand-name Ozempic?
Compounded semaglutide contains the identical active ingredient as Ozempic but is prepared in licensed 503A compounding pharmacies rather than mass-manufactured by a pharmaceutical company. PlexusDx sources from accredited facilities that follow FDA oversight standards. Both deliver the same clinical mechanism—GLP-1 receptor activation—and produce comparable weight loss results, but compounded semaglutide typically costs 50–70% less.
Which is better for weight loss: semaglutide or tirzepatide?
Clinical trials show tirzepatide produces slightly faster and more substantial weight loss (20–22% body weight) compared to semaglutide (15–17%), thanks to its dual GLP-1/GIP receptor action. However, individual response varies based on genetics, metabolism, and lifestyle. PlexusDx Precision Peptide Genetic Test helps predict which medication your body is more likely to respond to, allowing your clinician to recommend the best choice for your unique profile.
How much does PlexusDx semaglutide cost, and what if my dose increases?
PlexusDx compounded semaglutide injection starts at $149/month and remains flat regardless of dose escalation. Your dose may need to go up as your body adjusts—typically starting at 0.25 mg and increasing weekly—but your price won't change. This transparent, predictable pricing model eliminates surprise cost jumps that occur with some telehealth competitors.
Are there serious side effects with GLP-1 medications?
Common side effects include nausea, constipation, and mild gastrointestinal discomfort, especially during the first weeks of treatment. These typically diminish as your body adapts. Serious side effects are rare but can include pancreatitis or allergic reactions; PlexusDx clinicians screen for contraindications and monitor you monthly to catch any concerns early. If you have a personal or family history of medullary thyroid cancer, GLP-1s are contraindicated.
How does the Precision Peptide Genetic Test help my weight loss?
The Precision Peptide Genetic Test ($99 add-on after month one) maps 150+ genetic insights across 49 peptides and 14 metabolic pathways. It reveals your predisposition to GLP-1 responsiveness, insulin sensitivity, and appetite-regulation genetics. This data allows your PlexusDx clinician to personalize your medication selection (semaglutide vs. tirzepatide vs. combination), optimize your dose trajectory, and set realistic expectations for your weight loss timeline based on your unique biology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic and Thyroid Conditions: What to Know
Understanding Ozempic Dosing: What Is the Highest Dose You Can Get?